Children with fragile X syndrome who were given the antibiotic minocycline had less anxiety and improvements in attention span and communication skills, researchers said. The observations were made by parents, but were significant enough to prompt the National Fragile X Foundation to sponsor a preliminary clinical trial to test the drug in children ages 4 to 16.

Related Summaries